A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion

To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone with observation for eyes with vision loss associated with macular edema secondary to perfused central retinal vein occlusion (CRVO).Multicenter, randomized, clinical trial of 271 participants.Gain in visual acuity letter score of 15 or more from baseline to month 12.Seven percent, 27%, and 26% of participants achieved the primary outcome in...